Differences in transport mechanisms of trans-1-amino-3-[ 18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: Comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose

Molecular Imaging and Biology

Volumn 16, Issue 3, 2014, Pages 322-329

  Oka, Shuntaro ^a,e   Okudaira, Hiroyuki ^a   Ono, Masahiro ^a,b   Schuster, David M ^c   Goodman, Mark M ^c   Kawai, Keiichi ^b,d   Shirakami, Yoshifumi ^a  

^a Nihon Medi Physics   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FUKUI   (Japan)

^e NONE   (Japan)

Author keywords

Amino acid transporters; Glioma; Inflammatory cells; Prostate cancer

Indexed keywords

1 AMINO 3 FLUOROCYCLOBUTANECARBOXYLIC ACID FLUORINE F 18; AMINO ACID TRANSPORTER; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; SODIUM ION; TRACER; UNCLASSIFIED DRUG; 1-AMINO-3-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; CARBOXYLIC ACID; CYCLOBUTANE DERIVATIVE; FLUORINE; METHIONINE; METHIONINE METHYL ESTER;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CANCER PATIENT; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; GLIOMA CELL; GRANULOCYTE; IN VITRO STUDY; INFLAMMATORY CELL; MACROPHAGE; MALE; NONHUMAN; PH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; RAT; T LYMPHOCYTE; ANALOGS AND DERIVATIVES; ANIMAL; COMPARATIVE STUDY; HUMAN; INFLAMMATION; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CYCLOBUTANES; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; MALE; METHIONINE; PROSTATIC NEOPLASMS; RATS;

EID: 84902292262     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0693-0     Document Type: Article

References (34)

1. Fanti S, Franchi R, Battista G et al (2005) PET and PET-CT. State of the art and future prospects. Radiol Med 110:1-15 (Pubitemid 41415966)
2. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 10:1-18
3. 18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med 40:331-338
4. 11C]methionine and MRI [abstract]. J Nucl Med 47:79P.
5. 18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. J Nucl Med 48:46-55
6. 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas. Nucl Med Biol 40:808-815
7. 18F] FACBC) uptake. Am J Nucl Med Mol Imaging 3:85-96
8. Sfanos KS, De Marzo AM (2012) Prostate cancer and inflammation: the evidence. Histopathology 60:199-215
9. 18F- fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med 52:822-829
10. 14C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol 39:109-119
11. 18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nucl Med Biol 40:670-675
12. Hediger MA, Romero MF, Peng JB et al (2004) The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch 447:465-468 (Pubitemid 38241432)
13. +L neutral and basic AA transporter. Insights into the mechanisms of substrate recognition. J Biol Chem 275:20787-20793
14. 18F] Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29:1039-1046
15. 11C-methionine. J Nucl Med 47:679-688
16. Tsuyuguchi N, Sunada I, Ohata K et al (2003) Evaluation of treatment effects in brain abscess with positron emission tomography: comparison offluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 17:47-51 (Pubitemid 36417573)
17. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899
18. Segel GB, Simon W, Lichtman MA (1984) Multicomponent analysis of amino acid transport in human lymphocytes. Diminished l-system transport in chronic leukemic B lymphocytes. J Clin Invest 74:17-24 (Pubitemid 14086040)
19. Ishii T, Sugita Y, Bannai S (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J Cell Physiol 133:330-336 (Pubitemid 18000329)
20. Gmünder H, Eck HP, Dröge W (1991) Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones. Eur J Biochem 201:113-117
21. Iruloh CG, D'Souza SW, Fergusson WD et al (2009) Amino acid transport systems beta and A in fetal T lymphocytes in intrauterine growth restriction and with tumor necrosis factor-alpha treatment. Pediatr Res 65:51-56
22. Gaugitsch HW, Prieschl EE, Kalthoff F et al (1992) A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUA. J Biol Chem 267:11267-11273
23. Matsumoto Y, Satoh-Ueno K, Yoshimura A et al (1999) Identification and immunological characterization of a novel 40-kDa protein linked to CD98 antigen. Cell Struct Funct 24:217-226 (Pubitemid 29500365)
24. + T cells express transporters for both cysteine and cystine. Sci Rep 2:266
25. Fuchs BC, Bode BP (2005) Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15:254-266 (Pubitemid 41065034)
26. Newsholme P (2001) Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131:2515S-2522S
27. 11C]-glutamine for metabolic imaging of tumors. J Nucl Med 53:98-105
28. 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. J Nucl Med 53:1616-1624
29. Shreve PD, Anzai Y, Wahl RL (1999) Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19:61-77
30. Fossati G, Ricevuti G, Edwards SW et al (1999) Neutrophil infiltration into human gliomas. Acta Neuropathol 98:349-354 (Pubitemid 29440680)
31. 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 223:446-451
32. 18F-FLT. J Nucl Med 49:135-141
33. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49:694-699
34. Ohtsuki S, Uchida Y, Kubo Y, Terasaki T (2011) Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects. J Pharm Sci 100:3547-3559